Patent ID: 11873335
Assignee: PHANES THERAPEUTICS, INC.
Field: Measurement (Instruments)
Classification: CPC C  G  A | IPC A  C  G

Claim 2:
3. The isolated monoclonal antibody or antigen-binding fragment thereof of claim 1, comprising:
(a) a heavy chain variable region having the polypeptide sequence of SEQ ID NO: 120, and a light chain variable region having the polypeptide sequence of SEQ ID NO: 122;
(b) a heavy chain variable region having the polypeptide sequence of SEQ ID NO:9, and a light chain variable region having the polypeptide sequence of SEQ ID NO: 10;
(c) a heavy chain variable region having the polypeptide sequence of SEQ ID NO:3, and a light chain variable region having the polypeptide sequence of SEQ ID NO:4;
(d) a heavy chain variable region having the polypeptide sequence of SEQ ID NO: 13, and a light chain variable region having the polypeptide sequence of SEQ ID NO: 14;
(e) a heavy chain variable region having the polypeptide sequence of SEQ ID NO: 113, and a light chain variable region having the polypeptide sequence of SEQ ID NO: 117;
(f) a heavy chain variable region having the polypeptide sequence of SEQ ID NO: 113, and a light chain variable region having the polypeptide sequence of SEQ ID NO: 118;
(g) a heavy chain variable region having the polypeptide sequence of SEQ ID NO: 114, and a light chain variable region having the polypeptide sequence of SEQ ID NO: 117;
(h) a heavy chain variable region having the polypeptide sequence of SEQ ID NO:114, and a light chain variable region having the polypeptide sequence of SEQ ID NO:118;
(i) a heavy chain variable region having the polypeptide sequence of SEQ ID NO:115, and a light chain variable region having the polypeptide sequence of SEQ ID NO:117;
(j) a heavy chain variable region having the polypeptide sequence of SEQ ID NO:115, and a light chain variable region having the polypeptide sequence of SEQ ID NO:118;
(k) a heavy chain variable region having the polypeptide sequence of SEQ ID NO:116, and a light chain variable region having the polypeptide sequence of SEQ ID NO:117;
(l) a heavy chain variable region having the polypeptide sequence of SEQ ID NO:116, and a light chain variable region having the polypeptide sequence of SEQ ID NO:118;
(m) a heavy chain variable region having the polypeptide sequence of SEQ ID NO:119, and a light chain variable region having the polypeptide sequence of SEQ ID NO:121;
(n) a heavy chain variable region having the polypeptide sequence of SEQ ID NO:119, and a light chain variable region having the polypeptide sequence of SEQ ID NO:122;
(o) a heavy chain variable region having the polypeptide sequence of SEQ ID NO:119, and a light chain variable region having the polypeptide sequence of SEQ ID NO:123;
(p) a heavy chain variable region having the polypeptide sequence of SEQ ID NO:120, and a light chain variable region having the polypeptide sequence of SEQ ID NO:121; or
(q) a heavy chain variable region having the polypeptide sequence of SEQ ID NO:120, and a light chain variable region having the polypeptide sequence of SEQ ID NO:123.